Xavier Fabregat

979 total citations
27 papers, 740 citations indexed

About

Xavier Fabregat is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Xavier Fabregat has authored 27 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Xavier Fabregat's work include Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Xavier Fabregat is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Xavier Fabregat collaborates with scholars based in Spain. Xavier Fabregat's co-authors include Joan Carles, Josep Corominas, Núria Malats, Marta Salido, Ignasi Tusquets, Françesc Solé, Meritxell Bellet, Joan Albanell, Miquel Porta and S. Coll and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Xavier Fabregat

27 papers receiving 713 citations

Peers

Xavier Fabregat

ONCOL

SURGE

PRM

Melinda M. Mortenson United States

E. A. Eisenhauer Canada

Norio Noguchi Japan

Ying Tian China

Domenico Sergi Italy

Guilherme Cantuaria United States

Rahul Atul Parikh United States

Xi Cheng China

Denise McLain United States

Melinda M. Mortenson United States

Xavier Fabregat

488 ×1.2

ONCOL

220 ×0.9

143 ×0.7

440 ×2.4

SURGE

174 ×1.1

PRM

Citations per year, relative to Xavier Fabregat Xavier Fabregat (= 1×) peers Melinda M. Mortenson

Countries citing papers authored by Xavier Fabregat

Since Specialization

Citations

This map shows the geographic impact of Xavier Fabregat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Fabregat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Fabregat more than expected).

Fields of papers citing papers by Xavier Fabregat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Fabregat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Fabregat. The network helps show where Xavier Fabregat may publish in the future.

Co-authorship network of co-authors of Xavier Fabregat

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Fabregat. A scholar is included among the top collaborators of Xavier Fabregat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Fabregat. Xavier Fabregat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carles, Joan, Miguel Nogué, Josep María Macias i Solé, et al.. (2009). Phase II Study of Vinorelbine and Estramustine in Combination With Conformational Radiotherapy for Patients With High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 76(4). 1085–1091. 4 indexed citations

Carles, Joan, Emilio Esteban, José A. Martínez-Climent, et al.. (2007). Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer. Annals of Oncology. 18(8). 1359–1362. 47 indexed citations

Carles, Joan, Cristina Suárez, Carlos Mesía, et al.. (2006). Feasibilty study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function. Clinical & Translational Oncology. 8(10). 755–757. 16 indexed citations

Corominas, Josep, Ignacio Tusquets, Marta Salido, et al.. (2006). The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma. Cancer Genetics and Cytogenetics. 165(2). 151–156. 36 indexed citations

Montagut, Clara, Ignasi Tusquets, Berta Ferrer-Rosell, et al.. (2006). Activation of nuclear factor-κ B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocrine Related Cancer. 13(2). 607–616. 85 indexed citations

Carles, Joan, Mariano Monzó, Marta Amat, et al.. (2006). Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer. International Journal of Radiation Oncology*Biology*Physics. 66(4). 1022–1030. 69 indexed citations

Muro, Xavier García del, Andrés Poveda, J. Buesa, et al.. (2006). Phase II trial of temozolomide as first-line treatment for patients with advanced gynecological sarcoma: A Spanish Group for Research on Sarcomas (GEIS) and Spanish Ovarian Cancer Research Group (GEICO) study. Journal of Clinical Oncology. 24(18_suppl). 9570–9570. 1 indexed citations

Salido, Marta, Ignasi Tusquets, Josep Corominas, et al.. (2005). Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situhybridization and immunohistochemistry. Breast Cancer Research. 7(2). R267–73. 76 indexed citations

Porta, Miquel, Xavier Fabregat, Núria Malats, et al.. (2005). Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage. Clinical & Translational Oncology. 7(5). 189–197. 176 indexed citations

10.

Tusquets, Ignacio, Marta Salido, Josep Corominas, et al.. (2005). Characterization of HER1 (c-erbB1) Status in Locally Advanced Breast Cancer Using Fluorescence in situ Hybridization and Immunohistochemistry. Tumor Biology. 26(1). 25–30. 15 indexed citations

11.

Grau, Juan J., Joan Carles, Mariano Monzó, et al.. (2004). Expression of cyclooxygenase-2 mRNA (COX2-mRNA) in peripheral blood (PB) of head and neck cancer patients (HNC) and healthy controls (HC). Journal of Clinical Oncology. 22(14_suppl). 5521–5521. 5 indexed citations

12.

Bellet, Marina Maria, A. Pelegrí, J. Corominas, et al.. (2004). Phase II study of capecitabine (C) in combination with docetaxel (D) as neoadjuvant treatment in patients with locally advanced breast cancer (IIIA and IIIB stage). Journal of Clinical Oncology. 22(14_suppl). 752–752. 4 indexed citations

13.

Porta, Miquel, Núria Malats, Emily Morell, et al.. (1998). Decreased survival of patients with lung cancer admitted to a teaching hospital through the emergency department in Barcelona, Spain.. Journal of Epidemiology & Community Health. 52(2). 137–138. 7 indexed citations

14.

Carles, Joan, et al.. (1998). Phase II Study of Estramustine and Vinorelbine in Hormone-Refractory Prostate Carcinoma Patients. Acta Oncologica. 37(2). 187–191. 41 indexed citations

15.

Muro, Xavier García del, Catalina Vadell, G. Pérez Manga, et al.. (1998). Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis. European Journal of Cancer. 34(1). 193–195. 17 indexed citations

16.

Gallén, Manuel, et al.. (1997). Anal carcinoma: a 14 year experience.. PubMed. 89(1). 23–8. 1 indexed citations

17.

Agudo, Antonio, et al.. (1997). Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain. European Journal of Cancer. 33(8). 1256–1261. 45 indexed citations

18.

Abad, Albert, Cristina Grávalos, Albert Font, et al.. (1996). Phase II study of Mitonafide in advanced and relapsed colorectal cancer. Investigational New Drugs. 14(2). 223–225. 4 indexed citations

19.

Lloreta, Josep, Catalina Vadell, Xavier Fabregat, & Sérgio Serrano. (1994). Fibrolamellar Hepatic Tumor with Neurosecretory Features and Systemic Deposition of AA Amyloid. Ultrastructural Pathology. 18(1-2). 287–292. 21 indexed citations

20.

Agudo, Antonio, Agustí Barnadas, Cinta Pallarés, et al.. (1994). Lung cancer and cigarette smoking in women: A case‐control study in barcelona (Spain). International Journal of Cancer. 59(2). 165–169. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact